141
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases

, , , , , & show all
Pages 125-130 | Received 11 Jul 2017, Accepted 18 Dec 2017, Published online: 22 Dec 2017

References

  • Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538–549.
  • Muiznieks LD, Keeley FW. Molecular assembly and mechanical properties of the extracellular matrix: a fibrous protein perspective. Biochim Biophys Acta. 2013;1832:866–875.
  • Brodsky B, Persikov AV. Molecular structure of the collagen triple helix. Adv Protein Chem. 2005;70:301–339.
  • Seyer JM, Hutcheson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest. 1977;59:241–248.
  • Veidal S, Vassiliadis E, Bay-Jensen AC, et al. Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats. Fibrogenesis Tissue Repair. 2010;3:5.
  • Gelse K, Poschl E, Aigner T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55:1531–1546.
  • Shahin M, Schuppan D, Waldherr R, et al. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology. 1992;15:637–644.
  • Attallah AM, Mosa TE, Omran MM, et al. Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV. J Immunoassay Immunochem. 2007;28:155–168.
  • Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381:107–113.
  • Schytte S, Hansen M, Moller S, et al. Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Scand J Clin Lab Invest. 1999;59:627–633.
  • Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878–888.
  • Tiggelman AM, Boers W, Linthorst C, et al. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha. J Hepatol. 1995;23:295–306.
  • De Cesaris P, Starace D, Riccioli A, et al. Tumor necrosis factor-alpha induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J Biol Chem. 1998;273:7566–7571.
  • Jin X, Zimmers TA, Perez EA, et al. Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology. 2006;43:474.
  • Bansal MB, Kovalovich K, Gupta R, et al. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol. 2005;42:548–556.
  • Swiatkowska-Stodulska R, Bakowska A. Serum interleukin-6 concentrations in patients with alcoholic liver disease. Pol Merkur Lekarski. 2004;99:255–259.
  • Greenwel P, Schwartz M, Rosas M, et al. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest. 1991;65:644–653.
  • Murawaki Y, Kato S, Hirayama C. Hepatic collagen synthesis in patients with alcoholic and nonalcoholic liver disease. Gastroenterol Jpn. 1991;26:465–471.
  • Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol. 1989;77:221–225.
  • Buechler C, Haberl EM, Rein-Fischboeck L, et al. Adipokines in liver cirrhosis. Int J Mol Sci. 2017;18:1392.
  • Wiest R, Weigert J, Wanninger J, et al. Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis. Cytokine. 2011;53:178–183.
  • Wieckowska A, Papouchado BG, Li Z, et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372–1379.
  • Koivisto H, Hietala J, Niemelä O. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease. Am J Gastroenterol. 2007;102:773–779.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.